APLS is currently covered by 15 analysts with an average price target of $36.55. This is a potential upside of $33.43 (1071.47%) from yesterday's end of day stock price of $3.12.
Apellis Pharmaceuticals's activity chart (see below) currently has 529 price targets and 385 ratings on display. The stock rating distribution of APLS is 66.67% BUY, 29.63% HOLD and 3.7% SELL.
Analysts' price targets on this stock were met 67.23% of the time, taking 201.49 days on average.
Highest price target for APLS is $48, Lowest price target is $18, average price target is $36.55.
Most recent stock forecast was given by STEVEN SEEDHOUSE from CANTOR FITZGERALD on 15-May-2026. First documented stock forecast 04-Dec-2017.
Currently out of the existing stock ratings of APLS, 18 are a BUY (66.67%), 8 are a HOLD (29.63%), 1 are a SELL (3.7%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 15-May-2026
$31
6 months 3 days ago
(15-May-2026)
5/24 (20.83%)
$13.11 (73.28%)
332
Buy Since 20-Jan-2026
$41
$-0.03 (-0.07%)
$26
7 months 1 days ago
(17-Apr-2026)
17/20 (85%)
$0.1 (0.24%)
97
Buy Since 02-Apr-2026
$41
$-0.03 (-0.07%)
$31
7 months 16 days ago
(02-Apr-2026)
2/2 (100%)
$0.59 (1.46%)
26
Hold Since 01-Nov-2023
$41
$-0.03 (-0.07%)
$20
7 months 16 days ago
(02-Apr-2026)
14/18 (77.78%)
$0.59 (1.46%)
148
Buy Since 04-Dec-2017
$41
$-0.03 (-0.07%)
$44
7 months 17 days ago
(01-Apr-2026)
21/28 (75%)
$0.61 (1.51%)
201
What is APLS (Apellis Pharmaceuticals) average time for price targets to be met?
Which analyst most recently updated their price target on APLS (Apellis Pharmaceuticals)?
Which analyst has the most public recommendations on APLS (Apellis Pharmaceuticals)?
Which analyst is the currently most bullish on APLS (Apellis Pharmaceuticals)?
Which analyst is the currently most reserved on APLS (Apellis Pharmaceuticals)?